{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:52:21Z","timestamp":1793659941803,"version":"4.5.1"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejim.2020.05.042","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T07:53:11Z","timestamp":1591948391000},"page":"17-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review."],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2813-2083","authenticated-orcid":false,"given":"Cosimo","family":"Bruni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5306-7714","authenticated-orcid":false,"given":"Giacomo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Grazia","family":"Lazzaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Zanatta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Lepri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Air\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Doria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Matucci-Cerinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejim.2020.05.042_bib0001","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/art.23187","article-title":"High N\u2010terminal pro\u2013brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis","volume":"58","author":"Allanore","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"suppl_4","key":"10.1016\/j.ejim.2020.05.042_bib0002","doi-asserted-by":"crossref","first-page":"iv22","DOI":"10.1093\/rheumatology\/kel314","article-title":"Pulmonary arterial hypertension and rheumatic diseases\u2014from diagnosis to treatment","volume":"45","author":"Distler","year":"2006","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.ejim.2020.05.042_bib0003","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1378\/chest.08-3042","article-title":"Is pulmonary arterial hypertension really a late complication of systemic sclerosis?","volume":"136","author":"Hachulla","year":"2009","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.ejim.2020.05.042_bib0004","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1136\/annrheumdis-2012-202489","article-title":"Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era","volume":"72","author":"Launay","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.ejim.2020.05.042_bib0005","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12876","article-title":"Pulmonary arterial hypertension associated with connective tissue diseases: a review focusing on distinctive clinical aspects","volume":"48","author":"Kato","year":"2018","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.ejim.2020.05.042_bib0006","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJMoa1213917","article-title":"Macitentan and morbidity and mortality in pulmonary arterial hypertension","volume":"369","author":"Pulido","year":"2013","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.ejim.2020.05.042_bib0007","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02493-2016","article-title":"Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension","volume":"50","author":"Gaine","year":"2017","journal-title":"Eur Respir J"},{"issue":"7","key":"10.1016\/j.ejim.2020.05.042_bib0008","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/annrheumdis-2016-210236","article-title":"Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial","volume":"76","author":"Coghlan","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.ejim.2020.05.042_bib0009","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1378\/chest.13-3014","article-title":"Unique predictors of mortality in patients with pulmonary arterial hypertension associated with systemic sclerosis in the REVEAL registry","volume":"146","author":"Chung","year":"2014","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.ejim.2020.05.042_bib0010","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.semarthrit.2013.08.002","article-title":"Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review","volume":"43","author":"Gladue","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.ejim.2020.05.042_bib0011","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.semarthrit.2018.10.010","article-title":"Update of screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension","volume":"48","author":"Young","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.ejim.2020.05.042_bib0012","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Int Med"},{"issue":"11","key":"10.1016\/j.ejim.2020.05.042_bib0013","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an ACR-EULAR collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.ejim.2020.05.042_bib0014","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.ejim.2020.05.042_bib0015","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeROY","year":"2001","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.ejim.2020.05.042_bib0016","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00528-2018","article-title":"Global Lung Initiative equations for pulmonary hypertension screening in systemic sclerosis","volume":"52","author":"Soumagne","year":"2018","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.ejim.2020.05.042_bib0017","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","article-title":"Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study","volume":"52","author":"Hachulla","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.ejim.2020.05.042_bib0018","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3899\/jrheum.090997","article-title":"Comparison of brain natriuretic peptide (BNP) and NT-proBNP in screening for pulmonary arterial hypertension in patients with systemic sclerosis","volume":"37","author":"Cavagna","year":"2010","journal-title":"J Rheumatol"},{"issue":"11","key":"10.1016\/j.ejim.2020.05.042_bib0019","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3899\/jrheum.100245","article-title":"Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.ejim.2020.05.042_bib0020","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1002\/art.24525","article-title":"The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France","volume":"60","author":"Hachulla","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.ejim.2020.05.042_bib0021","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13075-017-1341-x","article-title":"Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension","volume":"19","author":"Morrisroe","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.ejim.2020.05.042_bib0022","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02275-2016","article-title":"Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort","volume":"49","author":"Vandecasteele","year":"2017","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ejim.2020.05.042_bib0023","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long\u2010term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.ejim.2020.05.042_bib0024","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.chest.2018.05.002","article-title":"Long-term outcomes in systemic sclerosis-associated pulmonary arterial hypertension from the pulmonary hypertension assessment and recognition of outcomes in scleroderma registry (PHAROS)","volume":"154","author":"Kolstad","year":"2018","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.ejim.2020.05.042_bib0025","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1002\/art.30541","article-title":"Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long\u2010term survival","volume":"63","author":"Humbert","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.ejim.2020.05.042_bib0026","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1183\/13993003.01032-2015","volume":"46","author":"Gali\u00e8","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2020.05.042_bib0027","series-title":"Seminars in arthritis and rheumatism","article-title":"Screening and diagnostic modalities for connective tissue disease-associated pulmonary arterial hypertension: a systematic review","author":"Gladue","year":"2014"},{"issue":"7","key":"10.1016\/j.ejim.2020.05.042_bib0028","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/annrheumdis-2013-203301","article-title":"Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study","volume":"73","author":"Coghlan","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ejim.2020.05.042_bib0029","doi-asserted-by":"crossref","first-page":"4058","DOI":"10.1016\/j.ijcard.2013.07.005","article-title":"Accuracy and precision of echocardiography versus right heart catheterization for the assessment of pulmonary hypertension","volume":"168","author":"D\u2019Alto","year":"2013","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ejim.2020.05.042_bib0030","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01904-2018","article-title":"Diagnosis of pulmonary hypertension","volume":"53","author":"Frost","year":"2019","journal-title":"Eur Respir J"},{"issue":"28","key":"10.1016\/j.ejim.2020.05.042_bib0031","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011437","article-title":"Prevalence of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease","volume":"97","author":"Niklas","year":"2018","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.ejim.2020.05.042_bib0032","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13075-017-1327-8","article-title":"High sensitivity and negative predictive value of the DETECT algorithm for an early diagnosis of pulmonary arterial hypertension in systemic sclerosis: application in a single center","volume":"19","author":"Guill\u00e9n-Del Castillo","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ejim.2020.05.042_bib0033","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/rheumatology\/kev327","article-title":"Application of the DETECT algorithm for detection of risk of pulmonary arterial hypertension in systemic sclerosis: data from a Czech tertiary centre","volume":"55","author":"Soukup","year":"2016","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.ejim.2020.05.042_bib0034","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13075-015-0517-5","article-title":"A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis","volume":"17","author":"Hao","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.ejim.2020.05.042_bib0035","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/heartjnl-2016-309981","article-title":"Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis","volume":"103","author":"Dumitrescu","year":"2017","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ejim.2020.05.042_bib0036","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/rheumatology\/keh067","article-title":"Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis","volume":"43","author":"Mukerjee","year":"2004","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.ejim.2020.05.042_bib0037","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01008-2017","article-title":"Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis","volume":"50","author":"Degano","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ejim.2020.05.042_bib0038","doi-asserted-by":"crossref","first-page":"R143","DOI":"10.1186\/ar3876","article-title":"N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study","volume":"14","author":"Thakkar","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ejim.2020.05.042_bib0039","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13075-017-1250-z","article-title":"Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme","volume":"19","author":"Morrisroe","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.ejim.2020.05.042_bib0040","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","article-title":"Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach","volume":"62","author":"Mukerjee","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ejim.2020.05.042_bib0041","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12890-016-0296-z","article-title":"Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study","volume":"16","author":"Morrisroe","year":"2016","journal-title":"BMC Pulmonary Med"},{"issue":"11","key":"10.1016\/j.ejim.2020.05.042_bib0042","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/S0954-6111(03)00254-3","article-title":"Significance of plasma N-terminal pro-brain natriuretic peptide in patients with systemic sclerosis-related pulmonary arterial hypertension","volume":"97","author":"Mukerjee","year":"2003","journal-title":"Respir Med"},{"issue":"12","key":"10.1016\/j.ejim.2020.05.042_bib0043","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/eurheartj\/ehi891","article-title":"Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension","volume":"27","author":"Williams","year":"2006","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.ejim.2020.05.042_bib0044","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.ejim.2020.05.042_bib0045","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00586-2019","article-title":"Impact of the revised haemodynamic definition on the diagnosis of pulmonary hypertension in patients with systemic sclerosis","volume":"54","author":"Jaafar","year":"2019","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ejim.2020.05.042_bib0046","first-page":"1005","article-title":"Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease","volume":"34","author":"Launay","year":"2007","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.ejim.2020.05.042_bib0047","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s10554-018-1299-z","volume":"34","author":"Hekimsoy","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"issue":"10","key":"10.1016\/j.ejim.2020.05.042_bib0048","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1445-5994.2008.01823.x","article-title":"Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis","volume":"39","author":"Phung","year":"2009","journal-title":"Intern Med J"},{"issue":"4","key":"10.1016\/j.ejim.2020.05.042_bib0049","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4250\/jcu.2016.24.4.312","article-title":"Prevalence of pulmonary arterial hypertension in Korean adult patients with systemic sclerosis: result of a pilot echocardiographic screening study","volume":"24","author":"Yoo","year":"2016","journal-title":"J Cardiovasc Ultrasound"},{"issue":"3","key":"10.1016\/j.ejim.2020.05.042_bib0050","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10067-011-1896-x","article-title":"Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic","volume":"31","author":"Jansa","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.ejim.2020.05.042_bib0051","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10067-017-3918-9","article-title":"Red blood cell distribution width as a related factor of pulmonary arterial hypertension in patients with systemic sclerosis","volume":"37","author":"Zhao","year":"2018","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.ejim.2020.05.042_bib0052","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/art.40534","article-title":"CCL21 as a potential serum biomarker for pulmonary arterial hypertension in systemic sclerosis","volume":"70","author":"Hoffmann\u2010Vold","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"2 Suppl 76","key":"10.1016\/j.ejim.2020.05.042_bib0053","first-page":"31","article-title":"Pulmonary hypertension in systemic sclerosis: prevalence, incidence and predictive factors in a large multicentric Italian cohort","volume":"31","author":"Iudici","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.ejim.2020.05.042_bib0054","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/acr.22547","article-title":"Cardiac biomarkers in systemic sclerosis: contribution of high\u2010sensitivity cardiac troponin in addition to N\u2010terminal pro\u2010brain natriuretic peptide","volume":"67","author":"Avouac","year":"2015","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.ejim.2020.05.042_bib0055","first-page":"106","article-title":"Utility of B-type natriuretic peptides in the assessment of patients with systemic sclerosis-associated pulmonary hypertension in the PHAROS registry","volume":"35","author":"Chung","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.ejim.2020.05.042_bib0056","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.3899\/jrheum.130400","article-title":"Combination of echocardiographic and pulmonary function test measures improves sensitivity for diagnosis of systemic sclerosis-associated pulmonary arterial hypertension: analysis of 2 cohorts","volume":"40","author":"Gladue","year":"2013","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.ejim.2020.05.042_bib0057","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1002\/art.30432","article-title":"Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations","volume":"63","author":"Meune","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ejim.2020.05.042_bib0058","series-title":"Seminars in arthritis and rheumatism","article-title":"A right ventricular diastolic impairment is common in systemic sclerosis and is associated with other target-organ damage","author":"Meune","year":"2016"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520302351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520302351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:30:44Z","timestamp":1760607044000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620520302351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":58,"alternative-id":["S0953620520302351"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2020.05.042","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review.","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2020.05.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}